Request Deal Involvement
Viking Global Investors led a $75m Series C funding round in 4D Molecular Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Evercore
legal advisors
Latham & Watkins
or
Principals
bidder
MIRAE ASSET FINANCIAL GROUP
bidder
QUAD INVESTMENT MANAGEMENT
bidder
AMZAK CAPITAL MANAGEMENT
bidder
OCTAGON INVESTMENTS
target
4D MOLECULAR THERAPEUTICS
bidder
VIKING GLOBAL INVESTORS
bidder
CASDIN CAPITAL
bidder
WALGREEN CO
bidder
THE LONGEVITY FUND
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite